Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-07
1997-12-16
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514313, 514314, 514307, 514309, 514310, 514326, 514397, 514422, 514444, 514445, 514448, 546153, 546155, 546157, 546159, 546162, 546163, 546167, 546141, 546142, 546143, 546144, 5462847, 546212, 546213, 5483151, 548527, 549 59, 549 60, 549 61, 549 62, 549 63, 549 64, 549 69, 549 70, A61K 3138, C07D33322
Patent
active
056985819
ABSTRACT:
The invention relates to heteroaroylguanidines of the formula I ##STR1## in which the substituents HA and R(1) to R(5) have the meanings given in the specification. These compounds exhibit very good antiarrhythmic properties and are outstandingly suitable for use as antiarrhythmic pharmaceuticals possessing a cardioprotective component for the prophylaxis and treatment of infarction and for the treatment of angina pectoris, in connection with which they also inhibit or strongly reduce, in a preventative manner, the pathophysiological processes associated with the genesis of ischemically induced damage, in particular associated with the elicitation of ischemically induced cardiac arrhythmias.
REFERENCES:
patent: 3622595 (1971-11-01), Marchetti
patent: 3752819 (1973-08-01), Philippe
patent: 4894376 (1990-01-01), Morad et al.
patent: 5002965 (1991-03-01), Ramwell et al.
patent: 5091394 (1992-02-01), Englert et al.
patent: 5260091 (1993-11-01), Locke et al.
patent: 5292755 (1994-03-01), Englert et al.
patent: 5364868 (1994-11-01), Englert et al.
patent: 5373024 (1994-12-01), Lang et al.
patent: 5416094 (1995-05-01), Lal et al.
patent: 5516805 (1996-05-01), Lang et al.
patent: 5547953 (1996-08-01), Weichert et al.
patent: 5559153 (1996-09-01), Schwark et al.
patent: 5567734 (1996-10-01), Schwark et al.
patent: 5571842 (1996-11-01), Kleemann et al.
patent: 5591754 (1997-01-01), Lang et al.
patent: 5631293 (1997-05-01), Kleemann et al.
Skvortsov et al., "Furyol-or tetrahydrofuroylguanidines," Chemical Abstracts, 79(9):352, Abstract No. 53170t (1973).
Stolyarchuk et al., "Synthesis of Furoylguanidines and Comparison of their Pharmacological Properties with the Properties of Furoylureas," Chemical Abstracts, 86(17):522, Abstract No. 121071h (1977).
Aleksashin et al., "Spectral Characteristics of Ureides, Thioureides, Isoselenoureides, and Guanidines," Chemical Abstracts 101(9):593, Abstract No. 72124v (1984).
Escobales et al, "Na+/Na+ Exhange and Na+/H+ Antiport in Rabbit Erythrocytes: Two Distinct Transport Systems," J. Membrane Biol., 120:41-49 (1991).
Schmid et al., "Na+/H+ Exchange in Porcine Cerebral Capillary Endothelial Cells is Inhibited by a Benzoylguanidine Derivative", Biochemical and Biophysical Research Communications, 184(1):112-117 (1992).
Dusing et al., "Zur Klinischen Bedeutung des Na+/H+-Antiports," Medizinische Klinik, 87(7):378-384 (1992), no translation available.
Fujimoto, "Isoxazolylcarbonylureas", Chemical Abstracts, 72(13):401, Abstract No. 66928b (1970).
Derwent Abstract of DE 2055727.
Derwent Abstract of EP 416499.
Derwent Abstract of WO 9304048.
Derwent Abstract of EP 556672.
Derwent Abstract of EP 556673.
Derwent Abstract of EP 556674.
Derwent Abstract of EP 589336.
Derwent Abstract of EP 590455.
Derwent Abstract of EP 639573.
Derwent Abstract of EP 577024.
Albus Udo
Kleemann Heinz-Werner
Lang Hans-Jochen
Scholz Wolfgang
Schwark Jan-Robert
Dahlen Garth M.
Hoechst Aktiengesellschaft
Ivy C. Warren
LandOfFree
Substituted N-heteroaroylguanidines, a process for their prepara does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted N-heteroaroylguanidines, a process for their prepara, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted N-heteroaroylguanidines, a process for their prepara will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206702